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Summary
 
Antigen receptor–triggered T-cell activation is mediated by the sequential action of the Src and
Syk/Zap-70 families of protein tyrosine kinases (PTKs). Previously, we reported that another
PTK termed p50
 
csk
 
 was a potent negative regulator of T-cell receptor (TCR) signaling because
of its ability to inactivate Src-related kinases. This inhibitory effect required the catalytic activ-
ity of Csk, as well as its Src homology (SH)3 and SH2 domains. Subsequent studies uncovered
that, via its SH3 domain, p50
 
csk
 
 was associated with PEP, a proline-enriched protein tyrosine
phosphatase (PTP) of unknown function expressed in hemopoietic cells. Herein, we have at-
tempted to identify the role of the Csk-PEP complex in T lymphocytes. The results of our ex-
periments showed that, like Csk, PEP was a strong repressor of TCR signaling. This property
was dependent on the phosphatase activity of PEP, as well as on the sequence mediating its
binding to p50
 
csk
 
. Through reconstitution experiments in Cos-1 cells, evidence was obtained
that Csk and PEP act synergistically to inhibit protein tyrosine phosphorylation by Src-related
kinases, and that this effect requires their association. Finally, experiments with a substrate-trap-
ping mutant of PEP suggested that PEP functions by dephosphorylating and inactivating the
PTKs responsible for T-cell activation. In addition to giving novel insights into the mecha-
nisms involved in the negative regulation of T-cell activation, these findings indicate that the
association of an inhibitory PTK with a PTP constitutes a more efficient means of inhibiting
signal transduction by Src family kinases in vivo.
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A
 
ctivation of T cells by antigen bound to MHC mole-
cules results in a rapid rise in protein tyrosine phos-
phorylation. This response predicates all subsequent events
of T-cell activation, including transcriptional activation,
lymphokine release, cytolysis, and proliferation. Whereas
the TCR, as well as the associated CD3 and 
 
z
 
 subunits, do
not possess intrinsic protein tyrosine kinase (PTK)
 
1
 
 activity,
the CD3 and 
 
z
 
 chains contain within their cytoplasmic do-
main a signaling sequence termed Immunoreceptor Ty-
rosine-based Activation Motif (ITAM). This sequence un-
dergoes rapid tyrosine phosphorylation in response to TCR
stimulation, thereby triggering a signaling cascade leading
to T-cell activation.
Based on analyses of genetically manipulated cells and re-
constitution experiments in nonlymphoid cells, evidence
has accumulated that TCR signaling is mediated by the se-
quential involvement of the Src and Syk/Zap-70 families
of PTKs. The Src family kinases Lck and FynT are respon-
sible for the initiation of T-cell activation, as a result of
their capacity to phosphorylate the ITAMs of the TCR
complex. Subsequently, the diphosphorylated ITAMs of
CD3/
 
z
 
 bind the tandem Src homology (SH)2 domains of
Zap-70 and, in some T-cell subsets, Syk. This association
results in tyrosine phosphorylation and activation of Zap-
70 and Syk. The Syk/Zap-70 family is involved in the am-
plification of TCR-induced signals, by causing tyrosine
phosphorylation of proteins such as phospholipase C-
 
g
 
1,
Vav, Slp-76, and LAT.
Src-related kinases possess, from the NH
 
2
 
 terminus to
the COOH terminus: (a) an NH
 
2
 
-terminal myristylation
signal needed for membrane targeting; (b) a unique do-
main, presumed to mediate interactions with specific regu-
lators; (c) SH3 and SH2 domains allowing associations with
proline-rich sequences and tyrosine phosphorylated pro-
 
1
 
Abbreviations used in this paper:
 
 ITAM, Immunoreceptor Tyrosine-based
Activation Motif; PTK, protein tyrosine kinase; PTP, protein tyrosine
phosphatase; SH, Src homology. 
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teins, respectively; (d) a linker domain involved in an in-
tramolecular regulatory mechanism (1–3); (e) a kinase re-
gion bearing a typical phosphotransfer motif, as well as an
autophosphorylation site involved in positive regulation;
and (f) a negative regulatory domain containing the major
site of in vivo tyrosine phosphorylation. Phosphorylation of
the COOH-terminal tyrosine triggers an intramolecular as-
sociation between the COOH terminus and the SH2 do-
main, thereby inactivating Src family kinases. Such a phos-
phorylation is not the result of autophosphorylation, but
rather is caused by another PTK termed Csk.
Csk is a 50-kD cytoplasmic PTK expressed in all cell
types, albeit in greater amounts in hemopoietic cells (4, 5).
It contains NH
 
2
 
-terminal SH3 and SH2 regions, in addi-
tion to a COOH-terminal catalytic domain. Previously, we
reported that Csk was a potent negative regulator of TCR
signaling (6). Furthermore, Csk was shown recently to
control the development of mature 
 
ab
 
 T cells from pre-
cursor thymocytes (7). These effects correlated with the
ability of Csk to phosphorylate the inhibitory COOH-ter-
minal tyrosine of Lck and FynT (6, 7). In addition, in at
least one of the two systems (6), it was dependent on the
SH3 and SH2 domains of Csk, implying that the associa-
tion with other cellular proteins was also critical for the ac-
tivity of Csk in vivo (8). Subsequent studies uncovered
that, by way of its SH3 domain, p50
 
csk
 
 is associated with
PEP (9), an intracellular protein tyrosine phosphatase
(PTP) contained in hemopoietic cells (10). Although the
biological significance of this association was not eluci-
dated, its high stoichiometry suggested that it may have an
important role. As recently reported for other kinase–phos-
phatase complexes (CaMKIV-PP2A and Erk2-MKP3) (11,
12), it is possible that PEP represses the activity of Csk, ei-
ther by dephosphorylating the inhibitory tyrosine of Src-
like enzymes or by regulating Csk itself. Alternatively, it is
conceivable that PEP cooperates with Csk to inhibit intra-
cellular signaling events.
Herein, we have examined the potential role of the Csk-
PEP association in signal transduction. We found that, like
Csk, PEP is a strong repressor of antigen receptor signaling
in T cells. Evidence was obtained that PEP and Csk coop-
erate to inhibit signaling by Src family kinases, and that this
cooperation requires their association.
 
Materials and Methods
 
Cells.
 
The previously described antigen-specific mouse T-cell
hybridoma BI-141 was maintained in RPMI medium supple-
mented with 10% fetal bovine serum and antibiotics (13). BI-141
derivatives expressing wild-type Csk, 
 
D
 
SH3 Csk, or the neomy-
cin phosphotransferase alone (Neo) have been reported previously
(5). All BI-141 clones were propagated in the presence of G418
(0.6 mg/ml). Cos-1 cells were grown in 
 
a
 
-MEM containing 10%
fetal bovine serum and antibiotics.
 
cDNAs and Antibodies.
 
The cDNAs for wild-type PEP, 
 
D
 
P1
PEP, wild-type Csk, 
 
D
 
SH3 Csk, wild-type FynT, kinase-inactive
(lysine 295 to arginine 295) Zap-70, and Tac-
 
z
 
 were reported
previously (6, 8, 9, 14, 15). Those coding for the aspartate 195 to
alanine 195 (D195A), cysteine 227 to serine 227 (C227S), and argi-
nine 233 to methionine 233 (R233M) mutants of PEP were created
by overlap extension PCR. All mutated cDNAs were sequenced to
verify that they did not contain unwanted mutations (data not
shown). Antibodies directed against PEP, Csk, PTP-PEST, phos-
photyrosine, Zap-70, Tac (mAb 7G7), 
 
z
 
 (mAb H146), and Fyn
were described elsewhere (6, 8, 9, 15–17).
 
Transfections.
 
BI-141 T cells were stably transfected by elec-
troporation (260 V, 960 
 
m
 
F) and selected in the presence of G418
(0.75 mg/ml). Monoclonal cell lines were derived by limiting di-
lution. Cells were tested for PEP expression by immunoblotting
with anti-PEP antibodies. All clones selected for our studies had
unchanged levels of TCR, CD3, CD45, and Thy-1, and re-
mained CD4 negative (data not shown). Cos-1 cells were tran-
siently transfected with Lipofectamine-plus (Bethesda Research
Laboratories) according to the protocol provided by the manu-
facturer, using a fixed total amount of DNA (8 
 
m
 
g). Cells were
harvested 24–48 h after transfection.
 
Immunoprecipitations and Immunoblots.
 
Cells were washed with
phosphate-buffered saline and lysed in TNE buffer (50 mM Tris-
HCl, pH 8.0, 1% Nonidet P-40, 2 mM EDTA) supplemented
with 10 
 
m
 
g/ml each of the protease inhibitors leupeptin, apro-
tinin, 
 
n
 
-tosyl-
 
l
 
-phenylalanine chloromethyl ketone (TPCK),
 
n
 
-p-tosyl-
 
l
 
-lysine chloromethyl ketone (TLCK), and PMSF, as
well as the phosphatase inhibitors sodium fluoride (50 mM) and
sodium orthovanadate (1 mM). Immunoprecipitations were per-
formed with the appropriate antibodies using equivalent amounts
of cellular lysate. Immune complexes were recovered using 
 
Staph-
ylococcus aureus
 
 protein A (Pansorbin; Calbiochem) or protein
A–Sepharose (Pharmacia Biotech). After washing three times in
TNE buffer containing sodium orthovanadate (1 mM), proteins
were eluted in sample buffer, boiled, and subjected to SDS-
PAGE. Immunoblots were performed according to a protocol
detailed previously (15), using 
 
125
 
I-protein A (Amersham Corp.)
unless specified.
 
Lymphokine Secretion Assays.
 
Cells were stimulated in tripli-
cate with the indicated concentrations of anti-TCR V
 
b
 
8 mAb
F23.1 coated on 96-well plastic plates. After a 24-h incubation,
supernatants were harvested and frozen at 
 
2
 
70
 
8
 
C to destroy any
carry-over cells. The presence of secreted lymphokines in the su-
pernatant was determined by measuring incorporation of tritiated
thymidine in the IL-2–dependent indicator cell line HT-2.
 
TCR-mediated Protein Tyrosine Phosphorylation.
 
BI-141 deriv-
atives were activated for the indicated periods of time at 37
 
8
 
C us-
ing biotinylated mAb F23.1 (30 
 
m
 
g/ml) and avidin (38 
 
m
 
g/ml).
They were then lysed in TNE buffer supplemented with protease
and phosphatase inhibitors, and equal amounts of total cellular ly-
sate were subjected to immunoprecipitation using the protocol
described above.
 
PTP Assay.
 
PEP variants were expressed by transient trans-
fection in Cos-1 cells as explained earlier. After washing with
PBS, they were lysed according to the usual protocol, except that
the phosphatase inhibitors were omitted. PEP polypeptides were
subsequently recovered by immunoprecipitation from 25 
 
m
 
g of
cellular lysate. After collecting the immune complexes with 
 
S.
aureus
 
 protein A, they were washed three times in lysis buffer,
followed by two washes in phosphatase assay buffer (25 mM Tris-
HCl, pH 7.2, 1 mg/ml BSA, 1 mM dithiothreitol). They were
resuspended in phosphatase assay buffer and incubated for the in-
dicated periods of time at 30
 
8
 
C with tyrosine phosphorylated
myelin basic protein (5 
 
m
 
M). Reactions were stopped by the
addition of 20% (wt/vol) trichloroacetic acid, followed by incu-
bation on ice. After centrifugation, the release of 
 
32
 
PO
 
4
 
 in the 
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Figure 1. Effect of PEP on
TCR-mediated lymphokine se-
cretion. (A) Expression of PEP
in BI-141 T cells. The abun-
dance of PEP in representative
cell lines was determined by
anti-PEP immunoblotting of
anti-PEP immunoprecipitates.
Lane 1, Neo.1; lane 2, Neo.3;
lane 3, Neo.5; lane 4, wt
PEP.68; lane 5, wt PEP.78; and
lane 6, wt PEP.82. The position
of a molecular mass marker is
shown on the right, whereas that
of PEP is indicated on the left.
Exposure: 10 h. (B) Association
of PEP with Csk. The associa-
tion of PEP with Csk was evalu-
ated by immunoblotting of anti-
Csk immunoprecipitates with an
anti-PEP serum. Lanes 1 and 2,
Neo.1; lanes 3 and 4, Neo.3;
lanes 5 and 6, wt PEP.68; and
lanes 7 and 8, wt PEP.78. The
migration of a molecular weight
marker is shown on the right;
that of PEP is indicated on the left. Exposure: 18 h. (C) Association of Csk with PEP. The association of Csk with PEP was determined by immunoblot-
ting of anti-PEP immunoprecipitates with anti-Csk antibodies. Lanes 1–4, Neo.5; and lanes 5–8, wt PEP.78. The migration of Csk is indicated on the
left. Exposure: 45 s (enhanced chemiluminescence). (D) TCR-mediated lymphokine secretion. Cells were stimulated for 24 h with the indicated con-
centrations of anti-TCR MAb F23.1 (abscissa) coated on plastic. Lymphokine production was assayed using the IL-2–dependent indicator cell line
HT-2. Thymidine incorporation is shown on the ordinate in cpm. All assays were done in triplicate.
 
supernatant was measured by scintillation counting. Immunopre-
cipitates obtained from cells transfected with vector alone were
used to measure spontaneous hydrolysis. In our calculations, this
amount was subtracted from those of PEP immunoprecipitates.
Preparation of tyrosine phosphorylated myelin basic protein was
performed using the Protein Tyrosine Phosphatase Assay System
(New England Biolabs, Inc.), according to the protocol provided
by the manufacturer. All experiments were conducted under lin-
ear assay conditions (data not shown).
 
Substrate Trapping.
 
Transfected Cos-1 cells were prepared as
above, except that they were lysed in a buffer containing 50 mM
Tris-HCl, pH 7.5, 1% Triton X-100, 200 mM sodium chloride,
5 mM iodoacetamide, and 1 mM benzamidine, supplemented
with leupeptin, aprotinin, TPCK, TLCK, PMSF, and sodium
fluoride. Subsequently, immunoprecipitations and immunoblots
were performed using the standard protocols.
 
Metabolic Labeling and Peptide Mapping Studies.
 
For 
 
32
 
P
 
i
 
 label-
ing, cells were incubated for 2 h in phosphate-free DMEM sup-
plemented with 1.0 mCi of 
 
32
 
P
 
i
 
 (carrier free; NEN Research
Products) per ml, and 2% dialyzed FCS. Cells were then washed
with phosphate-free medium and lysed in TNE buffer containing
protease and phosphatase inhibitors, as described above. FynT
polypeptides were recovered by immunoprecipitation and re-
solved in 8% SDS-PAGE. Cyanogen bromide cleavage was per-
formed as described elsewhere (18). Phospholabeled FynT pep-
tides were resolved in 18% SDS-polyacrylamide gels and detected
by autoradiography.
 
Results
 
Impact of PEP on Antigen Receptor–induced Lymphokine Se-
cretion.
 
To evaluate the role of PEP in T lymphocytes, we
opted to use the antigen-specific mouse T-cell line BI-141,
as it has proven very useful in ascertaining the role and reg-
ulation of cytoplasmic PTKs in T lymphocytes (6, 8, 15,
19). Cells were transfected by electroporation with a cDNA
coding for mouse PEP, and stable monoclonal cell lines
were selected after growth in G418-containing medium.
Derivatives overexpressing PEP were identified by immu-
noblotting of anti-PEP immunoprecipitates with anti-PEP
antibodies. Representative clones are shown in Fig. 1 A. In
comparison with control neomycin-resistant BI-141 cells
(Neo; lanes 1–3), these cells (lanes 4–6) contained three to
four times greater amounts of a 110-kD polypeptide con-
sistent with PEP.
Next, it was determined whether PEP overexpression
resulted in an increase in the abundance of Csk-PEP com-
plexes (Fig. 1, B and C). When anti-Csk immunoprecipi-
tates were probed by immunoblotting with anti-PEP anti-
bodies (Fig. 1 B), we observed that PEP overexpression
(lanes 5–8) induced a three- to fourfold increase in the
quantity of PEP that was coimmunoprecipitated with Csk.
As was the case for control Neo cells (lanes 1–4), 
 
z
 
50–80%
of PEP molecules contained in these cells were associated
with Csk (lanes 5–8). In a similar way, enforced expression
of PEP induced a proportional augmentation in the
amount of Csk that could be coimmunoprecipitated with
PEP (Fig. 1 C; compare lanes 2 and 6). Whereas 
 
z
 
5% of
Csk was associated with PEP in control Neo cells (lane 2),
this fraction was elevated to 
 
z
 
15% in PEP-overexpressing
cells (lane 6). PEP overexpression did not affect the ability
of Csk to associate with PTP-PEST, a PEP-related PTP
expressed ubiquitously (compare lanes 3 and 7) (16, 20).
Importantly, all cell lines used in our experiments expressed 
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unaltered levels of TCR, CD3, and CD45 (data not
shown).
The effect of PEP on antigen receptor–mediated lym-
phokine secretion, a late marker of T-cell activation (21,
22), was first evaluated (Fig. 1 D). Cells were stimulated
with increasing concentrations of anti-TCR mAb F23.1
immobilized on plastic, and the release of lymphokines in
the supernatant was monitored using a standard bioassay.
This analysis revealed that, compared to Neo cells, cells
overexpressing PEP had dramatically reduced lymphokine
production in response to TCR stimulation. This diminu-
tion was observed in all clones tested, and at all concentra-
tions of anti-TCR mAbs.
 
Structural Requirements for the Inhibitory Effect of PEP on
T-Cell Activation.
 
To begin elucidating the mechanism by
which PEP affected TCR signaling, the relevance of its
phosphatase activity was determined. To this end, catalyti-
cally defective PEP mutants in which either cysteine 227
was replaced by serine (C227S), or arginine 233 was substi-
tuted by methionine (R233M), were created. As described
for other phosphatases (23–25), mutation of these highly
conserved residues located in the catalytic domain strongly
diminished the ability of PEP to dephosphorylate the sub-
strate myelin basic protein in an immune complex phos-
phatase assay (Fig. 2 B; data not shown). When introduced
in BI-141 cells, the two PEP mutants (Fig. 2 A; lanes 7–11)
were expressed in quantities comparable to those of wild-
type PEP (lanes 4–6). Furthermore, they were able to asso-
ciate with Csk with a similar stoichiometry (Fig. 2 C; lanes
9–12). However, they were incapable of inhibiting TCR-
triggered lymphokine production (Fig. 2 D).
Then we examined the importance of the association of
p50
 
csk
 
 with PEP by testing the function in BI-141 cells of a
PEP mutant carrying a deletion in the proline-rich region
mediating binding to Csk (
 
D
 
P1 PEP; Fig. 3 A) (9, 26).
While this mutation did not affect the ability of PEP to de-
phosphorylate the exogenous substrate myelin basic protein
in vitro (Fig. 2 B), it significantly reduced (approximately
fivefold) its capacity to be coimmunoprecipitated with Csk
(Fig. 2 C; lanes 13–16). By opposition to our earlier finding
in Cos-1 cells (9, 26), there appeared to be a partial associa-
tion of 
 
D
 
P1 PEP with Csk in BI-141 cells. Although the
exact basis for this difference is undetermined, it is possible
that other structural determinants in PEP (such as the pro-
line-rich domain P2) mediated binding to Csk in the T-cell
line. In support of this notion, we reported elsewhere that
PEP P2 could also associate with the Csk SH3 domain in
vitro, albeit with a greatly reduced apparent affinity in
comparison with P1 (26). Alternatively, it is conceivable
that the presence of 
 
D
 
P1 PEP in BI-141 cells augmented
by an unknown mechanism the ability of endogenous PEP
molecules to associate with Csk. In any case, we observed
that 
 
D
 
P1 PEP failed to inhibit antigen receptor–mediated
lymphokine production in BI-141 cells (Fig. 3 B), indicat-
ing that the small (approximately twofold) increase in the
abundance of Csk-associated PEP in these cells was insuffi-
Figure 2. Role of phosphatase
activity of PEP. (A) Expression
of catalytically defective PEP
mutants. The expression levels of
PEP in representative cell lines
containing C227S PEP or
R233M PEP were determined as
for Fig. 1 A. Lane 1, Neo.1; lane
2, Neo.3; lane 3, Neo.5; lane 4,
wt PEP.68; lane 5, wt PEP.78;
lane 6, wt PEP.82; lane 7,
C227S PEP.19; lane 8, C227S
PEP.23; lane 9, C227S PEP.28;
lane 10, R233M PEP.1; and lane
11, R233M PEP.47. The posi-
tion of a molecular mass marker
is shown on the right, whereas
that of PEP is indicated on the
left. Exposure: 14 h. (B) Ty-
rosine phosphatase activity of
PEP mutants. The catalytic ac-
tivity of the PEP mutants was
measured by immune complex
phosphatase assay using radiola-
beled myelin basic protein as a
substrate. Immune complexes
were incubated with myelin ba-
sic protein for the indicated peri-
ods of time (abscissa). Release of inorganic phosphate was measured by scintillation counting and is shown on the ordinate (cpm). The abundance of the
various PEP mutants was also monitored by anti-PEP immunoblotting of parallel anti-PEP immunoprecipitates (inset). The position of PEP is indicated
on the left. Exposure: 12 h. (C) Association of PEP mutants with Csk. The ability of the PEP mutants to coimmunoprecipitate with Csk was assayed as
outlined for Fig. 1 B. Lanes 1 and 2, Neo.1; lanes 3 and 4, Neo.3; lanes 5 and 6, wt PEP.68; lanes 7 and 8, wt PEP.82; lanes 9 and 10, C227S PEP.19;
lanes 11 and 12, C227S PEP.23; lanes 13 and 14, DP1 PEP.3; and lanes 15 and 16, DP1 PEP.29. The migration of a molecular weight marker is indicated
on the right, while that of PEP is shown on the left. Exposure: 16 h. (D) Lymphokine production assay. Assay was carried out as described for Fig. 1 D. 
115
 
Cloutier and Veillette
 
cient to inhibit TCR signaling. The defective function of
 
D
 
P1 PEP was reminiscent of the inability of an SH3 do-
main–deleted version of Csk (
 
D
 
SH3 Csk) to suppress
TCR-mediated lymphokine secretion in BI-141 cells (8;
Fig. 3 B). From these data, we deduced that the inhibitory
effect of PEP on TCR-mediated lymphokine secretion not
only requires its phosphatase activity, but also is correlated
with the capacity to associate with Csk.
 
Impact of PEP on Antigen Receptor–mediated Protein Ty-
rosine Phosphorylation.
 
The influence of PEP overexpres-
sion on TCR-mediated protein tyrosine phosphorylation
was investigated next (Fig. 4). BI-141 cells were stimulated
for various periods of time at 37
 
8
 
C with biotinylated anti-
TCR mAb F23.1 and avidin. After stimulation, they were
lysed in detergent-containing buffer, and tyrosine phos-
phorylated proteins were immunoprecipitated and detected
by antiphosphotyrosine immunoblotting (Fig. 4 A). In
contrast to Neo cells (lanes 1–6), cells overexpressing PEP
(lanes 7–12) demonstrated a clear reduction in TCR-
induced protein tyrosine phosphorylation. Tyrosine phos-
phorylation of most, if not all, TCR-regulated substrates
was diminished approximately fourfold. The impact of PEP
on tyrosine phosphorylation of Zap-70 and the 
 
z
 
 subunit of
TCR, the two most proximal substrates in TCR signaling
(21, 22), was also specifically evaluated. Antiphospho-
tyrosine immunoblotting of Zap-70 immunoprecipitates
Figure 3. Importance of Csk-binding do-
main of PEP. (A) Expression of DP1 PEP.
The abundance of PEP in representative cell
lines expressing DP1 PEP was evaluated as
described in the legend of Fig. 1 A. Lane 1,
Neo.1; lane 2, Neo.3; lane 3, wt PEP.68;
lane 4, wt PEP.78; lane 5, wt PEP.82; lane
6, DP1 PEP.3; lane 7, DP1 PEP.7; lane 8,
DP1 PEP.29; and lane 9, DP1 PEP.34. The
position of a molecular mass marker is
shown on the right, whereas that of PEP is
indicated on the left. Exposure: 10 h. (B)
Lymphokine production assay. Assay was
carried out as described for Fig. 1 D.
Figure 4. Impact of PEP on TCR-medi-
ated protein tyrosine phosphorylation. (A)
Overall protein tyrosine phosphorylation.
Cells were stimulated for the indicated
times with biotinylated anti-TCR mAb
F23.1 and avidin. After cell lysis, tyrosine
phosphorylated proteins were immunopre-
cipitated with antiphosphotyrosine (aP.tyr)
antibodies and revealed by subsequent an-
tiphosphotyrosine immunoblotting. Lanes
1–3, Neo.1; lanes 4–6, Neo.3; lanes 7–9, wt
PEP.68; and lanes 10–12, wt PEP.78. The
migrations of prestained molecular mass
markers are indicated on the right, while
that of the H chain (Ig) is shown on the left.
Exposure: 16 h. (B) Tyrosine phosphoryla-
tion of Zap-70. Cells were activated as out-
lined for A, except that stimulation was for
2 min only. Tyrosine phosphorylation of
Zap-70 was monitored by immunoblotting
of anti–Zap-70 immunoprecipitates with
antiphosphotyrosine antibodies. Lanes 1 and
2, Neo.1; lanes 3 and 4, Neo.3; lanes 5 and
6, wt PEP.68; and lanes 7 and 8, wt
PEP.78. The migrations of prestained mo-
lecular weight markers are shown on the
right; those of c-Cbl, Zap-70, and H chain
(Ig) are indicated on the left. Exposure: 24 h.
(C) Tyrosine phosphorylation of z. Experiment was as for B, except that the z subunit of TCR was immunoprecipitated with anti-z mAb H146. Lanes 1 and
2, Neo.1; lanes 3 and 4, Neo.3; lanes 5 and 6, wt PEP.68; and lanes 7 and 8, wt PEP.78. The migrations of prestained molecular mass markers are indicated
on the right; those of Zap-70, H chain (Ig), and z (zeta) are shown on the left. Exposure: 12 h (using a PhosphorImager). (D) Effect of PEP mutants on
TCR-mediated protein tyrosine phosphorylation. Experiment was as outlined for A, except that cells expressing the various PEP mutants were studied. Cells
were stimulated for 2 min. Lanes 1 and 2, Neo.1; lanes 3 and 4, Neo.3; lanes 5 and 6, wt PEP.68; lanes 7 and 8, wt PEP.78; lanes 9 and 10, C227S PEP.28;
lanes 11 and 12, R233M PEP.1; lanes 13 and 14, R233M PEP.47; lanes 15 and 16, DP1 PEP.3; and lanes 17 and 18, DP1 PEP.29. The positions of
prestained molecular weight markers are shown on the right, whereas that of H chain (Ig) is indicated on the left. Exposure: 16 h. 
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(Fig. 4 B) showed that PEP (lanes 5–8) markedly reduced
the phosphotyrosine content of Zap-70 in TCR-stimulated
BI-141 cells. Tyrosine phosphorylation of c-Cbl, a 120-kD
adaptor molecule associated with Zap-70 (27, 28), was also
lowered. In a similar way, PEP diminished tyrosine phos-
phorylation of the ITAMs of 
 
z
 
 (Fig. 4 C), the first bio-
chemical change known to occur during T-cell activation
(21, 22).
Lastly, the structural requirements for the diminution of
TCR-induced protein tyrosine phosphorylation by PEP
were ascertained (Fig. 4 D). This analysis showed that, un-
like wild-type PEP (lanes 5–8), the two phosphatase-inac-
tive variants of PEP (lanes 9–14), as well as 
 
D
 
P1 PEP (lanes
15–18), were unable to inhibit TCR-triggered protein ty-
rosine phosphorylation.
 
Cooperative Inhibition of Protein Tyrosine Phosphorylation by
PEP and Csk Is Enhanced by Their Physical Association.
 
These findings demonstrated that, in a manner analogous to
Csk (6), PEP was a negative regulator of antigen receptor
signaling in T cells. Together with previously published re-
sults (8), they also indicated that the domains mediating the
physical association between Csk and PEP were critical for
the respective inhibitory impacts of these two molecules.
On this basis, it seemed plausible that Csk and PEP needed
to be associated with each other in order to inhibit TCR-
mediated signal transduction events. To further test this
possibility, attempts were made to recreate the influence of
Csk and PEP on TCR-mediated tyrosine phosphorylation
events in a heterologous system (Fig. 5). The Cos-1 cell
system was chosen for these studies, because it has been ex-
tensively validated to dissect the proximal events of TCR
signaling (17, 29, 30). Cells were transiently transfected
with cDNAs coding for a chimeric receptor containing the
cytoplasmic portion of 
 
z
 
 (Tac-
 
z
 
), the Src family kinase
FynT, and Zap-70. A kinase-inactive version of Zap-70
(lysine 295 to arginine 295 mutant) was used in these assays
to ensure that baseline protein tyrosine phosphorylation
was caused exclusively by FynT.
As described elsewhere (29), expression of wild-type
FynT allowed tyrosine phosphorylation of the 
 
z
 
 chimera
(Fig. 5 A; first panel, lane 1) and Zap-70 (second panel,
lane 1). Neither substrate was phosphorylated in cells lack-
ing FynT (data not shown). In the presence of FynT, Tac-
 
z
 
was also detectably associated with tyrosine phosphorylated
Zap-70 molecules (first and second panels, lane 1). In cells
overexpressing p50
 
csk
 
 alone (lane 2), there was a small
(
 
,
 
25%) diminution in the phosphotyrosine content of
Tac-
 
z
 
 and Zap-70. This decrease was more marked (30–
40%) in cells containing PEP alone (lane 3), although resid-
ual phosphorylation of Tac-
 
z
 
 and Zap-70 was clearly ob-
served. However, in contrast, cells coexpressing Csk and
PEP (lane 4) displayed a total abolition of tyrosine phos-
phorylation of both the chimeric receptor (first panel) and
Zap-70 (second panel). Similar results were obtained in
cells transfected with the Src-like enzyme Lck rather than
FynT (data not shown).
Since this system recapitulated the effects of Csk and
PEP on the initial events of TCR signaling, we wanted to
 
test whether the ability of these enzymes to associate was
important for their cooperation. Thus, mutants that were
defective in this association (
 
D
 
SH3 Csk and DP1 PEP; 9)
were evaluated (Fig. 5 B). Like wild-type p50csk or PEP
alone (Fig. 5 A, lanes 2 and 3), DSH3 Csk (Fig. 5 B, lane 3)
or DP1 PEP (lane 4) alone had a partial effect on tyrosine
phosphorylation of Tac-z (first panel) and Zap-70 (second
panel). However, contrary to wild-type Csk and PEP to-
gether (lane 2), coexpression of DSH3 Csk and DP1 PEP
(lane 5) could not eliminate tyrosine phosphorylation of
Tac-z and Zap-70. Together, these data supported the no-
tion that the optimal ability of PEP and Csk to inhibit pro-
tein tyrosine phosphorylation by Src family kinases re-
quired their physical association.
Identification of Potential PEP Substrates. The ability of PEP
overexpression in BI-141 cells to repress tyrosine phosphor-
ylation of most TCR-regulated substrates, including Zap-
70 and z, indicated that this phosphatase acted on a proxi-
mal step of TCR signaling. However, unfortunately, in
light of the complex interplay between Src family kinases,
ITAMs, and Zap-70, it was difficult to identify the imme-
diate targets of PEP using the T-cell system. To help iden-
tify the PEP substrates, substrate-trapping experiments
Figure 5. Cooperative inhibition of protein tyrosine phosphorylation
by Csk and PEP in Cos-1 cells. (A) Effects of wild-type Csk and PEP on
protein tyrosine phosphorylation in Cos-1 cells. Cos-1 cells were tran-
siently transfected with cDNAs coding for Tac-z, wild-type FynT, and
kinase-inactive Zap-70, in the absence or presence of Csk and/or PEP.
Tyrosine phosphorylation of Tac-z (top panel) and Zap-70 (second panel)
was examined by immunoblotting of either anti-Tac mAb 7G7 or anti–
Zap-70 immunoprecipitates with antiphosphotyrosine antibodies. The
expression of Csk (third panel), and PEP (bottom panel) was monitored
by immunoblotting of total cell lysates with the indicated antisera. Equiv-
alent expression of Tac-z, FynT, and Zap-70 in the transfected cell popu-
lations was confirmed by immunoblotting of cell lysates with the appro-
priate antibodies (data not shown). The migrations of Zap-70, Tac-z, H
chain (Ig), Csk, and PEP are indicated on the left. Exposures: 6 h. (B) Ef-
fects of DSH3 Csk and DP1 PEP on protein tyrosine phosphorylation in
Cos-1 cells. Experiment was as in A, except that cDNAs coding for
DSH3 Csk and DP1 PEP were used. Equivalent levels of Tac-z, FynT,
and Zap-70 were demonstrated by immunoblotting of total cell lysates
with the appropriate antibodies (data not shown). The migrations of
Zap-70, Tac-z, H chain (Ig), Csk, and PEP are indicated on the left. Ex-
posures: 5 h, except for the bottom panel (7 h).117 Cloutier and Veillette
were conducted in the Cos-1 system (Fig. 6). Cells were
transfected as described in Fig. 5, except that a PEP variant
carrying a replacement of a conserved aspartate in the cata-
lytic domain (aspartate 195 to alanine 195 mutant; D195A
PEP) was used. Mutation of the equivalent residue in other
PTPs has been shown to abolish their catalytic activity
while preserving the ability to associate with substrates (24,
31–33). Such a property has provided a very useful tool in
identifying targets of PTPs.
Immunoblotting of total cell lysates with antiphosphoty-
rosine antibodies showed that, when compared with wild-
type PEP (Fig. 6 A, lane 3), D195A PEP (lane 5) was less
efficient at repressing protein tyrosine phosphorylation in
Cos-1 cells. Nonetheless, it was clearly able to reduce the
tyrosine phosphorylation of certain substrates, especially
Tac-z. Furthermore, the mutant could cooperate with Csk
(lane 6) to inhibit protein tyrosine phosphorylation, albeit
to a lesser degree than wild-type PEP (lane 4). The ability
of D195A PEP to repress protein tyrosine phosphorylation
may appear paradoxical, especially since the catalytic activ-
ity of this mutant was found to be abolished in in vitro
phosphatase assays (data not shown). However, these results
are consistent with the findings of others (33). Seemingly,
substrate-trapping mutants of other PTPs can interfere with
protein tyrosine phosphorylation as a result of steric hin-
drance.
To identify which proteins were the immediate sub-
strates of PEP, PEP molecules were recovered by immuno-
precipitation and probed by antiphosphotyrosine immuno-
blotting (Fig. 6 B, top panel). This experiment revealed
that D195A PEP (lanes 5 and 6) associated with a major
tyrosine phosphorylated polypeptide of z70 kD. This
association occurred independently of coexpression of Csk
(compare lanes 5 and 6). Small quantities of a z59-kD
phosphotyrosine–containing protein were also present in
PEP immunoprecipitates. Unlike D195A PEP, wild-type
PEP (lanes 3 and 4) was not associated with any detectable
tyrosine phosphorylated protein. This difference was not
caused by variations in the levels of expression of the two
forms of PEP, as revealed by reprobing of the immunoblot
membrane with anti-PEP serum (bottom panel).
To characterize the tyrosine phosphorylated proteins as-
sociated with D195A PEP, anti-PEP immunoprecipitates
were also probed by immunoblotting with antibodies
against either Zap-70, FynT, or Tac-z (Fig. 6 C). This
analysis revealed that D195A PEP (lanes 5 and 6) formed a
stable complex with Zap-70 (first panel) and FynT (second
panel). However, it was not detectably associated with
Tac-z (third panel). It is noteworthy that the ability of
D195A PEP to associate with FynT and Zap-70 was not
influenced by the presence of Csk (compare lanes 5 and 6),
implying that Csk did not mediate these interactions.
When compared with D195A PEP, wild-type PEP (lanes 3
and 4) bound much smaller quantities of Zap-70 and FynT,
in keeping with the results obtained with substrate-trapping
mutants of other phosphatases (31, 32). Thus, the results of
these experiments suggested that PEP inhibited TCR sig-
naling by dephosphorylating Zap-70 and FynT, but not z. 
PEP Induces Dephosphorylation of the Positive Regulatory
Site of FynT, Tyrosine 417. Like other Src family kinases,
FynT is regulated by phosphorylation of two distinct ty-
rosine residues (5, 34, 35). Phosphorylation of the major
site of autophosphorylation, tyrosine 417, is involved in the
activation of FynT. In contrast, phosphate occupancy of
the COOH-terminal tyrosine residue, tyrosine 528, which
is mediated by Csk, causes an inhibition of the catalytic
function of FynT. To assess which of these residues
was(were) targeted for dephosphorylation by PEP, peptide
mapping studies were conducted (Fig. 7). Cos-1 cells were
transfected with cDNAs coding for wild-type FynT, Tac-z
and kinase-inactive Zap-70 as above, in the absence or
presence of wild-type PEP. Subsequently, they were la-
Figure 6. Identification of po-
tential PEP substrates by sub-
strate trapping. (A) Effect of
D195A PEP on protein tyrosine
phosphorylation in Cos-1 cells.
Cos-1 cells were transiently
transfected as for Fig. 5 A. Ap-
propriate levels of expression of
Tac-z, FynT, Zap-70, and Csk
were documented by immuno-
blotting of total cell lysates with
the appropriate antibodies (data
not shown). The migrations of
Zap-70, Tac-z and PEP are indi-
cated on the left, whereas those
of prestained molecular weight
markers are shown on the right.
Exposures: 13 h. (B) Association
of tyrosine phosphorylated proteins with D195A PEP. Lysates from the experiment shown in A were immunoprecipitated with anti-PEP antibodies and
probed by immunoblotting with either antiphosphotyrosine (aP.tyr; top panel) or anti-PEP antibodies (bottom panel). The positions of the 70- and 59-
kD tyrosine phosphorylated proteins are indicated on the left, whereas those of prestained molecular weight markers are shown on the right. Exposures:
top panel, 13 h; bottom panel, 7 h. (C) Identification of tyrosine phosphorylated proteins associated with D195A PEP. Experiment was as in A and B, ex-
cept that PEP immunoprecipitates and total cell lysates were immunoblotted with anti–Zap-70, anti-Fyn, or anti-z antibodies. The positions of Zap-70,
FynT, and Tac-z are shown on the left. Exposures: top three panels, 48 h; bottom three panels, 13 h.118 Role of Csk-PEP in T Cells
beled metabolically with 32Pi, and FynT molecules were
isolated by immunoprecipitation (Fig. 7 A). Gel electro-
phoresis revealed that FynT obtained from cells lacking
PEP (lane 1) migrated as a phosphorylated product of 59
kD, in addition to a species of z65 kD (FynT*). The exist-
ence of a similar form of FynT, having a retarded electro-
phoretic mobility, was shown previously to correlate with
FynT activation (36). In comparison, FynT polypeptides
recovered from cells expressing PEP (lane 2) were resolved
as a single phosphorylated product of 59 kD. Little or no
FynT* was found in these cells.
To identify more precisely the sites of phosphorylation
on these molecules, the phosphorylated products were
cleaved with cyanogen bromide and the resulting fragments
were resolved in 18% SDS-PAGE gel (Fig. 7 B). Previous
studies demonstrated that cleavage of FynT with cyanogen
bromide produces three major phosphorylated peptides:
C1 (21 kD), which contains NH2-terminal sites of serine
and threonine phosphorylation; C2 (9.6 kD), which pos-
sesses tyrosine 417; and C3 (4.2 kD), which bears tyrosine
528 (37–39). To help identify the C2 fragment, a peptide
map of constitutively activated tyrosine 528 to phenylala-
nine 528 (F528) FynT was performed in parallel (lane 5).
This mutant is known to be extensively phosphorylated at
tyrosine 417 (38).
We observed that the 59-kD FynT molecules in cells
lacking PEP (Fig. 7 B, lane 1) were phosphorylated within
the tyrosine 528–containing C3 peptide and to a lesser,
albeit appreciable extent, the tyrosine 417–bearing C2
peptide. Phosphorylation within the NH2-terminal C1
fragment was also present. The 65-kD products (lane 3)
were more prominently phosphorylated within the tyrosine
417–containing C2 peptide, relative to the C3 fragment.
This finding is consistent with the notion that FynT* rep-
resented activated FynT molecules. In cells expressing PEP
(lane 2), there was no reduction in the extent of phos-
phorylation of p59fynT within the tyrosine 528–bearing C3
peptide. However, phosphorylation at tyrosine 417 was
abolished. Furthermore, the existence of FynT* was abro-
gated (lane 4). Even though the global extent of phosphor-
ylation in the C1 fragment was not altered by the presence
of PEP, the electrophoretic mobility of this peptide was
noticeably faster (lane 2). The exact basis for this difference
is not known. Thus, in combination, these data indicated
that PEP caused dephosphorylation of tyrosine 417, but
not of tyrosine 528, of FynT.
Discussion
Previously, we found that the ability of Csk to inhibit
T-cell activation required the presence of its SH3 domain
and that, through this region, Csk interacted at a high
stoichiometry with the proline-enriched protein tyrosine
phosphatase PEP (8, 9). Herein, we demonstrated that, like
Csk, PEP was a strong negative regulator of antigen recep-
tor–mediated protein tyrosine phosphorylation and lym-
phokine secretion in T cells. This effect required the phos-
phatase activity of PEP, and correlated with the capacity of
PEP to bind to Csk. Reconstitution experiments in Cos-1
cells provided further support for the idea that PEP and
Csk cooperate to inhibit TCR signaling, and that this syn-
ergism is dependent on their association. Finally, studies us-
ing a substrate-trapping mutant of PEP suggested that PEP
inhibited TCR signaling by dephosphorylating the Src-
related enzymes themselves and at least one of their targets,
the protein tyrosine kinase Zap-70.
These observations suggested that the SH3 domain of
Csk is needed for its inhibitory function in T cells because
it mediates binding to PEP (or a PEP-related phosphatase;
see below). Although it is formally possible that this do-
main also interacts with other proteins contributing to its
activity, it should be mentioned that we and others have
failed to identify additional ligands for the Csk SH3 region
(9 and references therein). Taking into consideration the
similar impact of Csk and PEP on TCR signaling, the high
stoichiometry and specificity of their association, and the
structural requirements for their respective inhibitory ef-
fects, it appears likely that the ability of Csk and PEP to in-
hibit TCR signaling requires their physical association.
Through its dual ability to inactivate Src-related enzymes
by phosphorylating their COOH-terminal tyrosine and
to dephosphorylate critical TCR-regulated substrates, the
Csk-PEP complex constitutes a potent mechanism to inac-
Figure 7. Peptide mapping studies. (A) Immunoprecipitations. Cells
were metabolically labeled with 32Pi, as outlined in Materials and Methods.
After lysis, FynT polypeptides were recovered by immunoprecipitation
(IP) and analyzed by SDS-PAGE. The positions of prestained molecular
mass markers are shown on the right. Those of the 59- and 65-kD species
of FynT (FynT*) are indicated on the left. Exposure: 13 h. (B) Cyanogen
bromide cleavage. Radiolabeled FynT was cleaved with cyanogen bro-
mide and the resulting fragments were resolved in 18% SDS-PAGE gels.
Phosphorylated products were detected by autoradiography. To allow bet-
ter identification of the fragment (C2) containing the site of autophosphor-
ylation of FynT, tyrosine 417, a peptide map of radiolabeled F528 FynT
from cells treated with pervanadate is shown in lane 5. Under these condi-
tions, the mutant FynT protein is extensively phosphorylated at tyrosine
417. The presence of a phosphorylated C3 fragment in this lane was due to
contamination of the immunoprecipitates with endogenous Fyn molecules
from Cos-1 cells. The positions of C1 (which contains NH2-terminal sites
of serine and threonine phosphorylation), C2 (which contains tyrosine
417), and C3 (which bears tyrosine 528) are shown on the left. The migra-
tions of prestained molecular mass markers are indicated on the right. Ex-
posure: Lanes 1, 2, and 5, 3.5 h; lanes 3 and 4, 9 h.119 Cloutier and Veillette
tivate T cells. The purpose of this kinase–phosphatase com-
plex is clearly different from that of CaMKIV-PP2A, Erk2-
MKP3, and Lck-CD45, in which the associated phosphatase
directly regulates the activity of the kinase (11, 12, 40).
We found that enhanced PEP expression in BI-141 T
cells caused a diminution in tyrosine phosphorylation of
most TCR-regulated substrates, including Zap-70 and the
ITAMs of z. Given the complex regulatory interactions be-
tween Src family kinases, ITAMs, and Zap-70, it is difficult
to determine whether PEP acted by dephosphorylating and
inactivating the ITAMs, Zap-70, and/or the positive regu-
latory site of Src family kinases. To help resolve this issue,
we attempted to identify the immediate target(s) of PEP
using a substrate-trapping variant of PEP (D195A PEP). In
transiently transfected Cos-1 cells, this mutant was found to
associate with Zap-70 and FynT. A similar association
could be seen with Lck (data not shown). By contrast,
D195A PEP did not interact with z. Hence, these findings
suggested that PEP inhibited TCR signaling by regulating
Zap-70 and Src family kinases, and that the reduction in
ITAM phosphorylation in PEP-overexpressing cells was sec-
ondary to inactivation of Src-related enzymes. Of course, we
cannot exclude the possibility that PEP also dephosphorylated
more downstream targets in the TCR signaling cascade.
It is unlikely that the impact of PEP in BI-141 cells was
the nonspecific consequence of overexpression of an irrele-
vant PTP. Firstly, the biochemical and biological effects of
PEP were seen with moderate degrees (three- to fourfold)
of overexpression. Secondly, and most importantly, they
were not noted in cells containing DP1 PEP, a PEP variant
that was defective in the ability to associate with Csk, but
that remained catalytically active. On this basis, we feel
confident that the effects of PEP in these cells were genu-
ine, and that they reflected a physiological role of PEP in
TCR signaling. The inability of phosphatase-inactive ver-
sions of PEP (C227S and R233M PEP) to behave as domi-
nant-negative mutants and enhance TCR signaling in BI-
141 cells may be viewed as a contradiction of this model.
However, it should be remembered that z5% of Csk is as-
sociated with endogenous PEP molecules. As indicated in
Fig. 1 C, there remains a large pool of presumably unoccu-
pied Csk molecules than can accommodate additional PEP
polypeptides. Consequently, it is not surprising that expres-
sion of the phosphatase-inactive mutants had no effect on
TCR signaling, as they would not be expected to displace
the endogenous PEP from Csk.
In addition to PEP, other PTPs have been implicated in
the control of T-cell activation. The transmembrane PTP
CD45 was shown to be a positive regulator of TCR signal-
ing, as a consequence of its ability to dephosphorylate the
negative regulatory site of Src-like kinases (41, 42). SHP-1
and SHP-2, two PTPs bearing tandem SH2 domains at
their NH2 termini, have also been linked to this process.
There is evidence that SHP-1 has an inhibitory impact on
T-cell activation (43–45), and that it can be activated by ty-
rosine phosphorylated Zap-70 (45) or, in some T-cell sub-
sets, inhibitory receptors such as KIRs and LAIR-1 (46,
47). In comparison, the function of SHP-2 is less certain.
Whereas it has been proposed to be a negative regulator of
TCR signaling based on its association with the inhibitory
receptor CTLA-4 (48), recent studies with dominant-nega-
tive SHP-2 mutants have suggested an opposite role (49).
Finally, other phosphatases such as PAC-1 and HePTP
have been found to inhibit T-cell activation by acting on
more downstream events of TCR signaling, such as MAP
kinase activation (50, 51). Thus, in a manner analogous to
protein tyrosine kinases, several PTPs appear to be in-
volved in regulating protein tyrosine phosphorylation in T
cells. Even though certain PTPs, especially SHP-1, share
substrates with PEP, these enzymes are most probably reg-
ulated by distinct mechanisms. As a result, they are likely to
be involved in different aspects of T-cell inactivation. Ad-
ditional studies, including determination of the mechanism
by which Csk-PEP is recruited to the site of Src family ki-
nase activation, should help to substantiate this notion.
As p50csk is ubiquitous and PEP is also expressed in he-
mopoietic cells other than T cells, the Csk-PEP complex
may provide a similar function in cell types such as B cells
and macrophages. Furthermore, it is noteworthy that Csk
also associates via its SH3 domain with PTP-PEST (16), a
PEP-related PTP contained in all cell lineages (20). Since
the SH3 region of Csk seems to be critical for its function
in nonhemopoietic cells (52–54), the inhibitory kinase may
also cooperate with PTP-PEST in these cells. In keeping
with this notion, it was reported that expression of the cat-
alytic domain of PTP-PEST was able to suppress the lethal
effect of Src in yeast cells, seemingly by dephosphorylating
its substrates (55). Hence, a complex between Csk and a
PTP could have a generalized role in the regulation of Src
family kinases in vivo.
Because of the central role played by Src family kinases
in cell signaling, significant interest has been directed towards
understanding their regulation. Earlier studies showed that
Csk-mediated phosphorylation of the COOH-terminal tyro-
sine of Src-like enzymes decreases their catalytic activity, by
allowing an intramolecular interaction between the phos-
phorylated COOH terminus and the SH2 domain (5, 34,
56). However, as revealed by recent structural data (1, 2),
this phosphorylation is not sufficient for full inactivation of
Src-related enzymes. Other mechanisms, including a docu-
mented intramolecular association between their SH3 do-
main and linker region, are involved in additional inhibi-
tion. The data presented in this report raise the possibility
of a novel facet in this regulation, by suggesting that a com-
plex between Csk and a PTP is also critical to repress sig-
naling by Src family kinases in vivo.
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